http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018635-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c19aaa6b5ffdbeb95eaafc820ff0cb86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_923f977240d6b825bd271ea3fe657c70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38738593527b0ea668bc7492e742793e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_deaa2078e5c0b62f0a38b9f4896b3913
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b726e239a099c1f71230b1bf3666c4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c600ce86632d43b50aca5687d3ce58e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
filingDate 2004-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dcf44a6284acc1d7cebc7a8c0a66405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae9ff686456426c609091d0474cf1810
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ec95360c7d15e6ecc68e22d99b2066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33c5424fe1645521cda3a31efe744c80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c6297cca97970000dc6fa4fe62be14d
publicationDate 2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005018635-A3
titleOfInvention Ion channel modulating activity i
abstract Methods, compositions, dosing regimes, and routes of administration for the treatment or prevention of arrhythmias. In these methods, early afterdepolarizations and prolongation of QT interval may be reduced or eliminated by administering ion channel modulating compounds to a subject in need thereof. The ion channel modulating compounds may be cycloalkylamine ether compounds, particularly cyclohexylamine ether compounds. Also described are compositions of ion channel modulating compounds and drugs which induce early afterdepolarizations, prolongation of QT interval and/or Torsades de Pointes.
priorityDate 2003-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9950225-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9508544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03105756-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0196335-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227941878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227941879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67152429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57455055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67152428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227941877

Total number of triples: 42.